Synthesis and characterization of multiply-tyrosinated, multiply- iodinated somatostatin analogs

Journal of Peptide Research

Volumn 53, Issue 2, 1999, Pages 201-213

  Woltering, Eugene A ^a,f   O'Dorisio, M S ^e   Murphy, W A ^b   Chen, F ^e   Drouant, G J ^a   Espenan, G D ^a   Fisher, D R ^c   Sharma, C ^a   Diaco, D S ^a   Maloney, T M ^d   Fuselier, J A ^b   Nelson, J A ^a   O'Dorisio, T M ^e   Coy, D H ^b  

^a LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^d Iso Tex   (United States)

^e OHIO STATE UNIVERSITY   (United States)

^f Chief Sect of Surg Endocrinology   (United States)

Author keywords

Growth hormone; In situ radiotherapy; Neuroblastoma; Pituitary cells; Radiation; Scintigraphy; Somatostatin; Somatostatin receptors

Indexed keywords

SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CANCER CELL CULTURE; MASS SPECTROMETRY; NEUROBLASTOMA CELL; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; RADIOIODINATION; RADIOISOTOPE DIAGNOSIS; RADIOLYSIS; RECEPTOR BINDING; SCINTIGRAPHY; TUMOR LOCALIZATION;

EID: 0033019252     PISSN: 1397002X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1397-002X.1999.00019.x     Document Type: Article

References (26)

1. 1 Reubi, J.C., Heitz, P.U. & Gyr, K. (1987) Vasoactive intestinal peptide producing tumour contains high density of somatostatin receptors [letter]. Lancet 1, 741-742.
2. 2 Bogden, A.E., Taylor, J.E., Moreau, J.-P, Coy, D.H. & LePage, D.J. (1990) Response of human lung tumor xenografts to treatment with a somatostatin analogue (somatuline). Cancer Res. 50, 4360-4365.
3. 3 Woltering, E.A., O'Dorisio, M.S. & O'Dorisio, T.M. (1995) The role of radiolabeled somatostatin analogs in the management of cancer patients. In Principles and Practice of Oncology Updates (DeVita Jr, V.T., Hellman, S. & Rosenberg, V.T.). Lippincott-Raven Publishers, Philadelphia, pp. 1-16.
4. 125I-TYR(3)-octreotide and a hand-held gamma-detecting probe. Surgery 114, 745-752.
5. 5 Martinez, D.A., O'Dorisio, M.S., O'Dorisio, T., Qualman, S.J., Caniano, D.A., Teich, S., Besner, G.E. & King, D.R. (1995) Intraoperative detection and resection of occult neuroblastoma: a technique exploiting somatostatin receptor expression. J. Pediatric Surg. 30, 1580-1589.
6. 125I-lanerotide in women with primary breast carcinoma. Proc. Soc. Surg. Oncol. 38-38.
7. 7 O'Dorisio, M.S., Chen, F., Wray, D.A., Qualman, S.J. & O'Dorisio, T.M. (1994) Identification of somatostatin receptors on human neuroblastoma tumors. Cell Growth Diff. 5, 1-8.
8. 8 Lamberts, S.W., Hofland, L.J., van Koetsveld, P.M., Reubi, J.C., Bruinging, H.A., Bakker, W.H. & Krenning, E.P. (1990) Parallel in vivo and in vitro detection of functional somatostatin receptors in human endocrine pancreatic tumors: consequences with regard to diagnosis, localization, and therapy. J. Clin. Endocrinol. Metab. 71, 566-574.
9. 9 McCarthy, K.E., Woltering, E.A., Espenan, G.D., Cronin, M.J., Maloney, T. & Anthony, L.B. (1998) In situ radiotherapy with 111Inpentetreotide: initial observations and future directions. Cancer J. Sci. Am. 4, 93-102.
10. 10 Krenning, E.P., Kooij, P.P., Bakker, W.H., Breeman, W.A., Postema, P.T.E, Kwekkeboom, D.J., Oei, H.Y., de Jong, F.H., Visser, T.J. & Reijs, A.E.M (1994) Radiotherapy with a radiolabeled somatostatin analog, [111In-DTPA-D-Phe1]-octreotide. A case history. Ann. N.Y. Acad. Sci. 733, 496-506.
11. 11 Bakker, W.H., Breeman, W.A., van der Pluijm, M.E., de Jong, M, Visser, T.J. & Krenning, E.P. (1996) Iodine-131 labeled octreotide: not an option for somatostatin-reception therapy. Eur. J. Nucl. Med. 23, 775-781.
12. 12 Murphy, W.A., Taylor, J.E., Moreau, J.P. & Coy, D.H. (1989) Novel heptapeptide somatostatin analog displays anti-tumor activity independent of effects on growth hormone secretion. Peptide Res. 2, 128-132.
13. 13 Tumilowicz, J.J., Nichols, W.W., Cholon, J.J. & Greene, A.E. (1970) Definition of a continuous human cell line derived from neuroblastoma. Cancer Res. 30, 2110-2118.
14. 14 O'Dorisio, M.S., Fleshman, D.J., Qualman, S.J. & O'Dorisio, T.M. (1992) Vasoactive intestinal peptide: autocrine growth factor in neuroblastoma. Regul. Peptide 37, 213-226 (abstract).
15. 15 Sato, H., Ota, Z. & Ogawa, N. (1989) Biochemical and pharmacological characterization of somatostatin receptors in rat brain. Res. Commun. Chem. Pathol. Pharmacol. 66, 203-218.
16. 16 Chen, F., O'Dorisio, M.S., Hermann, G., Hayes, J., Malarkey, W.B. & O'Dorisio, T.M. (1993) Mechanisms of action of long-acting analogs of somatostatin. Regul. Peptide 44. 285-295 (abstract).
17. 17 Munson, P.J. & Rodbard, D. (1980) LIGAND: a versatile computerized approach for the characterization of ligand binding systems. Anal. Biochem. 107, 220-239.
18. 18 McPherson, G.A. (1985) Analysis of radioligand binding experiments: a collection of computer programs for the IBM PC. J. Pharm. Meth. 14, 213-228.
19. 19 O'Dorisio, M.S., Vandenbark, G.R. & LoBuglio, A.F. (1979) Human monocyte killing of Staphylococcus aureus: modulation by agonists of cyclic adenosine 3',5'-monophosphate and cyclic guanosine 3',5'-monophosphate. Infect. Immun. 604-610.
20. 20 Siegel, J.A., Stubbs, J.B., Thomas, S.R., Stabin, M.G., Hays, M.T., Robertson, J.S., Wessels, B.W., Fisher, D.R., Weber, D.A. & Koral, K.F. and other contributors for the MIRD Committee (1996) Techniques for Quantitative Radiopharmaceutical Biodistribution Data Acquisition and Analysis for Use in Human Radiation Dose Estimates.
21. 21 Loevinger, R., Budinger, T.F. & Watson, E.E. (1991) MIRD Primer for Absorbed Dose Calculations. Rev. edn. New York, Society of Nuclear Medicine.
22. 22 Snyder, W.S., Ford, M.R. & Warner, G.G. (1978) Estimates of Specific Absorbed Fractions for Photon Sources Uniformly Distributed in Various Organs of a Heterogeneous Phantom New York, Society of Nuclear Medicine.
23. 23 O'Dorisio, M.S., Chen, F., Albers, A., Woltering, E.A., O'Dorisio, T.M., Murphy, W. & Coy, D. (1996) Development of a novel somatostatin analogue with high affinity for human sst1 and sst2. Regul. Peptide 64, 145 (abstract).
24. 1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation. Life Sci. 49, 1583-1591.
25. 3]-octreotide: the Rotterdam experience with more than 1,000 patients. Eur. J. Nucl. Med. 20, 716-731.
26. 26 Meyers, M.O., Woltering, E.A., Drouant, G., Maloney, T. & Anthony, C.T. (1997) Multiply radioiodinated somatostatin analogs induce receptor specific cytotoxicity. J. Surg. Res. (in press).